Y-Intercept (HK)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
30,640
+17,895
| +140% | +$1.87M | 0.08% | 388 |
|
|
2025
Q1 | $1.49M | Buy |
+12,745
| New | +$1.49M | 0.1% | 263 |
|
|
2024
Q4 | – | Sell |
-7,958
| Closed | -$715K | – | 1180 |
|
|
2024
Q3 | $715K | Sell |
7,958
-3,617
| -31% | -$325K | 0.04% | 598 |
|
|
2024
Q2 | $932K | Buy |
+11,575
| New | +$932K | 0.05% | 519 |
|
|
2024
Q1 | – | Sell |
-11,285
| Closed | -$898K | – | 1363 |
|
|
2023
Q4 | $898K | Buy |
+11,285
| New | +$898K | 0.08% | 353 |
|
|
2022
Q3 | – | Sell |
-7,715
| Closed | -$295K | – | 960 |
|
|
2022
Q2 | $295K | Buy |
7,715
+941
| +14% | +$36K | 0.04% | 590 |
|
|
2022
Q1 | $280K | Buy |
+6,774
| New | +$280K | 0.06% | 475 |
|
|
2021
Q3 | – | Sell |
-3,634
| Closed | -$245K | – | 643 |
|
|
2021
Q2 | $245K | Buy |
+3,634
| New | +$245K | 0.06% | 476 |
|
|
2021
Q1 | – | Sell |
-6,637
| Closed | -$553K | – | 620 |
|
|
2020
Q4 | $553K | Buy |
+6,637
| New | +$553K | 0.23% | 128 |
|